Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Apr;28(4):1016-1019.
doi: 10.1681/ASN.2016121321. Epub 2017 Feb 28.

Low Sodium Diet, Vitamin D, or Both for RAASi-Resistant, Residual, Proteinuria in CKD? The ViRTUE Trial Points the Way Forward but Is Not the Last Word

David Goldsmith  1   2 , Ravi I Thadhani  3   4
Affiliations
Editorial

Low Sodium Diet, Vitamin D, or Both for RAASi-Resistant, Residual, Proteinuria in CKD? The ViRTUE Trial Points the Way Forward but Is Not the Last Word

David Goldsmith et al. J Am Soc Nephrol. 2017 Apr.
No abstract available

Keywords: Trial; Vitamin D; proteinuria.

PubMed Disclaimer

Comment on

References

    1. Matsushita K, Ballew SH, Coresh J: Cardiovascular risk prediction in people with chronic kidney disease. Curr Opin Nephrol Hypertens 25: 518–523, 2016 - PMC - PubMed
    1. Dizin E, Hasler U, Nlandu-Khodo S, Fila M, Roth I, Ernandez T, Doucet A, Martin PY, Feraille E, de Seigneux S: Albuminuria induces a proinflammatory and profibrotic response in cortical collecting ducts via the 24p3 receptor. Am J Physiol Renal Physiol 305: F1053–F1063, 2013 - PubMed
    1. Viazzi F, Bonino B, Cappadona F, Pontremoli R: Renin-angiotensin-aldosterone system blockade in chronic kidney disease: Current strategies and a look ahead. Intern Emerg Med 11: 627–635, 2016 - PubMed
    1. Abe M, Okada K, Maruyama T, Maruyama N, Matsumoto K: Comparison of the antiproteinuric effects of the calcium channel blockers benidipine and amlodipine administered in combination with angiotensin receptor blockers to hypertensive patients with stage 3-5 chronic kidney disease. Hypertens Res 32: 270–275, 2009 - PubMed
    1. Culshaw GJ, MacIntyre IM, Dhaun N, Webb DJ: Endothelin in nondiabetic chronic kidney disease: Preclinical and clinical studies. Semin Nephrol 35: 176–187, 2015 - PubMed

LinkOut - more resources